Publications
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Mathematics and Physics, Second Faculty of Medicine
- Adalimumab fot the treatment of perianal fistulas in patients with Crohn's disease. Commented report on the post hoc analysis of the CHARM and ADHERE studies.2009 | First Faculty of Medicine
- Guidelines for the use of biological therapy in inflammatory bowel diseases2008 | First Faculty of Medicine, Central Library of Charles University
- Commentary [to article Infliximab, adalimumab and cerolizumab pegol in treatment of Crohn´s disease]2008 | First Faculty of Medicine
- Adalimumab in a Clinical Practice - Experience with Human Anti TNF-alpha Therapy in Tertiary Clinical CenterPublication without faculty affiliation
- Efficacy of Intensification Regimes of Biologic Therapy in Patients With Inflammatory Bowel Disease and Secondary Non-Response: Experience of a Single Referral CentrePublication without faculty affiliation
- Sustainability of biologic treatment in paediatric patients with Crohn's disease: population-based registry analysis2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Complicated course of IBD in pregnancy2023 | First Faculty of Medicine, Central Library of Charles University
- Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study2023 | First Faculty of Medicine
- Správná odpověď na kvíz : Fatální průběh zánětlivého onemocnění2023 | First Faculty of Medicine
Loading network view...